Acquired Hypofibrinogenemia
What is Acquired Hypofibrinogenemia?
Acquired hypofibrinogenemia is a rare bleeding disorder that happens when your blood has too little fibrinogen. Fibrinogen is a protein made by your liver that helps your blood clot. When levels drop too low, your body struggles to stop bleeding.
Unlike inherited bleeding disorders, this condition develops later in life. It often shows up during serious medical events like massive bleeding, severe liver disease, or certain cancer treatments. Your body either stops making enough fibrinogen or uses it up faster than it can be replaced.
Normal fibrinogen levels range from 200 to 400 milligrams per deciliter of blood. When levels fall below 100, bleeding risks increase significantly. This condition requires medical attention because it can lead to dangerous bleeding episodes if left untreated.
Symptoms
- Prolonged bleeding from cuts or injuries that won't stop
- Easy bruising even from minor bumps
- Bleeding gums during brushing or flossing
- Frequent nosebleeds that are hard to control
- Heavy menstrual periods in women
- Blood in urine or stool
- Bleeding into joints causing pain and swelling
- Internal bleeding in severe cases
Some people have mild cases with few obvious symptoms until they face surgery or injury. Early detection through blood testing helps prevent serious bleeding complications.
Concerned about Acquired Hypofibrinogenemia? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Acquired hypofibrinogenemia develops when your liver cannot make enough fibrinogen or your body uses it too quickly. Severe liver disease like cirrhosis reduces production because the liver makes all fibrinogen. Massive bleeding from trauma or surgery depletes fibrinogen stores faster than they can be replaced. Some cancers, especially blood cancers, trigger processes that break down fibrinogen abnormally.
Certain medical treatments can also lower fibrinogen levels. Fibrinolytic therapy, used to dissolve dangerous blood clots, intentionally breaks down fibrinogen. Snake bites from some species contain venom that destroys fibrinogen. Disseminated intravascular coagulation, a serious condition where clotting and bleeding happen at the same time, rapidly consumes fibrinogen throughout the body. Rarely, the immune system makes antibodies that attack fibrinogen molecules.
How it's diagnosed
Doctors diagnose acquired hypofibrinogenemia through blood tests that measure fibrinogen levels. A fibrinogen test shows how much of this clotting protein is in your blood. Levels below 100 milligrams per deciliter indicate hypofibrinogenemia. Your doctor may also order clotting time tests to see how well your blood forms clots.
Rite Aid offers fibrinogen testing as an add-on to our blood testing panel at Quest Diagnostics locations nationwide. Getting tested helps identify low levels before serious bleeding happens. Your doctor will also look for underlying causes like liver disease or recent bleeding events to guide treatment.
Treatment options
- Fibrinogen replacement therapy through IV infusions to restore normal levels
- Cryoprecipitate transfusions that contain concentrated fibrinogen
- Fresh frozen plasma transfusions for emergency bleeding situations
- Treatment of underlying causes like liver disease or cancer
- Stopping medications that might worsen bleeding
- Avoiding aspirin and blood thinners unless medically necessary
- Protecting yourself from injuries and trauma
- Regular monitoring of fibrinogen levels to adjust treatment
- Working with a hematologist who specializes in bleeding disorders
Need testing for Acquired Hypofibrinogenemia? Add it to your panel.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Acquired hypofibrinogenemia develops later in life from medical conditions or treatments. Congenital hypofibrinogenemia is inherited from birth due to genetic mutations. Acquired cases are more common and usually result from liver disease, massive bleeding, or certain medical treatments. Treatment approaches differ based on the underlying cause.
Fibrinogen levels can drop rapidly during massive bleeding or trauma within hours. In liver disease, levels typically decline gradually over months or years. During fibrinolytic therapy, levels drop intentionally within hours as part of treatment. The speed depends entirely on what is causing the deficiency.
Yes, many cases can be reversed by treating the underlying cause. Fibrinogen levels often return to normal once liver function improves or bleeding stops. Replacement therapy with fibrinogen concentrate provides immediate but temporary improvement. Long-term outcomes depend on successfully managing the root condition.
Levels below 100 milligrams per deciliter increase bleeding risk significantly. Levels under 50 are considered critically low and require urgent treatment. At these levels, your blood cannot form stable clots. Even minor injuries can lead to serious bleeding that is difficult to control.
A healthcare worker draws blood from a vein in your arm. The sample goes to a lab where technicians measure fibrinogen concentration. Results typically come back within 24 to 48 hours. No special preparation is needed before the test in most cases.
Fibrinolytic drugs like tissue plasminogen activator intentionally lower fibrinogen to dissolve clots. Some chemotherapy drugs affect liver function and reduce fibrinogen production. L-asparaginase, used for certain cancers, can significantly decrease fibrinogen levels. Always discuss medication side effects with your doctor.
Severe liver disease often leads to low fibrinogen because the liver produces all fibrinogen. However, mild liver disease may not lower levels significantly. Cirrhosis and acute liver failure are most likely to cause hypofibrinogenemia. Your doctor monitors fibrinogen as part of assessing liver function severity.
It can occur after surgery involving massive blood loss. Large transfusions dilute fibrinogen and other clotting factors. Cardiac surgery and trauma surgery carry higher risk. Surgeons monitor fibrinogen levels during complex procedures and replace it when necessary.
Avoid contact sports and activities with high injury risk. Use soft toothbrushes and electric razors to prevent bleeding. Tell all healthcare providers about your condition before procedures. Wear medical alert identification in case of emergencies.
Monitoring frequency depends on the underlying cause and severity. Active bleeding or treatment may require daily or weekly checks. Stable chronic conditions might need testing every few months. Your hematologist creates a personalized monitoring schedule based on your specific situation.